StonvexLoading…
StonvexStonvexStonvexCore line items from HP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.89B | $981.13M | $3.68B | $2.72B |
Operating Income | $-96.83M | $-59.91M | $3.32M | $4.78M |
Net Income | $-155.31M | $-96.71M | $-163.69M | $-106.33M |
EPS (Diluted) | $-1.57 | $-0.98 | $-1.66 | $-1.08 |
Total Assets | $6.34B | $6.46B | $6.71B | $6.86B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $177.20M | $247.19M | $196.85M | $166.07M |
Free Cash Flow OCF − CapEx | $88.58M | $114.86M | $116.58M | $-26.23M |
Shares Outstanding | 99.92M | 99.85M | 99.45M | 99.43M |